((自动化翻译由路透提供，请见免责声明 ))
路透耶路撒冷11月6日 - 梯瓦制药工业 首席执行官理查德-弗朗西斯（Richard Francis）周三表示，预计将与即将上任的特朗普政府开展富有成效的合作。
"弗朗西斯在这家以色列制药商发布强劲的第三季度业绩后对路透说："我们的工作一如既往，就是与任何政府进行富有成效的合作，我们已经证明了我们能做到这一点，我们也绝对会做到这一点。
不过他表示，要等到特朗普上台后才能明确他的医疗保健和制药政策。
弗朗西斯还表示，他预计 2025 年公司将 "一如既往"，品牌药将增长，仿制药业务将继续增长，生物仿制药的销售也将增加。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.